Allied Market Research published a report, titled, “Immunohistochemistry Market by Product (Antibody, Reagents, Kits, Equipment), by Application (Diagnosis, Research Applications, Forensic), by End User (Hospital and Diagnostic Labs, Research Institutes and Academic Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031.” According to the report, the global immunohistochemistry industry generated $2.4 billion in 2021, and is expected to reach $4.5 billion by 2031, manifesting a CAGR of 6.5% from 2022 to 2031.
Download Sample Report- https://www.alliedmarketresearch.com/request-sample/11564
Immunohistochemistry is a technique that is used to diagnose numerous chronic illnesses like cancer and cardiovascular and infectious diseases. It is a highly sensitive method that allows the localization of antigens within a cell or a tissue with high resolution. The method is based on the use of a primary antibody that specifically binds to its complementary antigen.
Key Players :
| Agilent Technologies Inc, Abcam Plc, F hoffman La Roche, Merck Kgaa, Biorad Laboratories, Thermofischer Scientific Inc, Cell Signaling Technology, Inc, Bio SB, Takara Bio, Inc, PHC Holdings Corporation, Miltenyi Biotec, CANDOR Bioscience GmbH, Sakura Finetek Japan Co., Ltd, Eagle Biosciences, Inc., Biocare Medical, LLC, Elabscience, Inc., Biogenex Laboratories |
Get detailed COVID-19 impact analysis on the Immunohistochemistry Market- https://www.alliedmarketresearch.com/request-for-customization/11564?reqfor=covid
Drivers, Restraints, and Opportunities
The increase in chronic diseases and increasing research and development activities across the world are driving the growth of the global immunohistochemistry market. However, the lack of skilled professionals and skilled workers is hindering the growth of the market. On the other hand, increasing collaboration between law enforcement and the pharmaceutical and biotech industry creates new opportunities in the coming years.
By application, the market is segmented into diagnosis, research application, and forensics. The diagnosis segment is further fragmented into cancer, infectious diseases, autoimmune diseases, nephrological diseases, neurological diseases, and other diseases. The research application is further classified into drug testing and others.By end user, the market is categorized into hospitals & diagnostic laboratories, academic & research institutes, and other end users .By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Asia-Pacific is anticipated to witness lucrative growth, owing to an increase in medical tourism, implementation of new ICT guidelines in Japan, investments, and reforms to modernize China’s healthcare infrastructure, rapid growth in the healthcare industry in India support the market growth in this region.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the immunohistochemistry market analysis from 2021 to 2031 to identify the prevailing immunohistochemistry market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the immunohistochemistry market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global immunohistochemistry
By Region:
North America (U.S., Canada, Mexico)
Europe (UK, Italy, Spain, Rest of Europe, Germany, France)
Asia-Pacific (Japan, China, Australia, India, South Korea, Rest Of Asia Pacific)
LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/11564
𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
> Ankylosing spondylitis market > https://www.alliedmarketresearch.com/ankylosing-spondylitis-market-A10266
> Neurorehabilitation Market > https://www.alliedmarketresearch.com/neurorehabilitation-market-A10461
> Over The Counter (OTC) Test Market > https://www.alliedmarketresearch.com/otc-tests-market-A10465
> Hemostats Market > https://www.alliedmarketresearch.com/hemostats-market-A16840
> Cardiac rehabilitation market> https://www.alliedmarketresearch.com/cardiac-rehabilitation-market-A11270
> Compounding Pharmacies Market > https://www.alliedmarketresearch.com/compounding-pharmacies-market-A11920